GoodRx Holdings Inc (NASDAQ: GDRX) on Friday, soared 6.31% from the previous trading day, before settling in for the closing price of $4.28. Within the past 52 weeks, GDRX’s price has moved between $4.09 and $9.26.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 19.48%. The company achieved an average annual earnings per share of 22.52%. With a float of $86.69 million, this company’s outstanding shares have now reached $103.93 million.
Let’s determine the extent of company efficiency that accounts for 694 employees. In terms of profitability, gross margin is 84.0%, operating margin of 5.82%, and the pretax margin is -0.58%.
GoodRx Holdings Inc (GDRX) Insider Activity
Observing investor behavior towards Health Information Services industry stocks is more important than anything else. The insider ownership of GoodRx Holdings Inc is 77.24%, while institutional ownership is 17.90%. The most recent insider transaction that took place on Dec 02 ’24, was worth 471,451. Before that another transaction happened on Sep 03 ’24, when Company’s 10% Owner sold 10,677 for $7.86, making the entire transaction worth $83,922. This insider now owns 0 shares in total.
GoodRx Holdings Inc (GDRX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.52% per share during the next fiscal year.
GoodRx Holdings Inc (NASDAQ: GDRX) Trading Performance Indicators
GoodRx Holdings Inc (GDRX) is currently performing well based on its current performance indicators. A quick ratio of 5.48 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.19. Likewise, its price to free cash flow for the trailing twelve months is 11.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.04, a number that is poised to hit 0.10 in the next quarter and is forecasted to reach 0.40 in one year’s time.
Technical Analysis of GoodRx Holdings Inc (GDRX)
Looking closely at GoodRx Holdings Inc (NASDAQ: GDRX), its last 5-days average volume was 1.48 million, which is a jump from its year-to-date volume of 1.35 million. As of the previous 9 days, the stock’s Stochastic %D was 25.10%. Additionally, its Average True Range was 0.22.
During the past 100 days, GoodRx Holdings Inc’s (GDRX) raw stochastic average was set at 9.77%, which indicates a significant decrease from 63.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.40% in the past 14 days, which was lower than the 55.01% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.85, while its 200-day Moving Average is $6.84. However, in the short run, GoodRx Holdings Inc’s stock first resistance to watch stands at $4.68. Second resistance stands at $4.81. The third major resistance level sits at $5.04. If the price goes on to break the first support level at $4.31, it is likely to go to the next support level at $4.08. Should the price break the second support level, the third support level stands at $3.95.
GoodRx Holdings Inc (NASDAQ: GDRX) Key Stats
Market capitalization of the company is 1.73 billion based on 381,142K outstanding shares. Right now, sales total 750,270 K and income totals -8,870 K. The company made 195,250 K in profit during its latest quarter, and 3,970 K in sales during its previous quarter.
